Keyphrases
Blood Pressure Control
100%
Angiotensin
100%
Chronic Renal Insufficiency
100%
Angiotensin-converting Enzyme Inhibitor (ACEi)
100%
Enzyme Inhibitors
100%
Antihypertensive Medication
66%
Mean Arterial Pressure
33%
Nephrology
33%
Blood Pressure Target
33%
Proteinuria
33%
Therapeutic Strategies
16%
Hypertension
16%
Canada
16%
Systolic Blood Pressure
16%
Diastolic Blood Pressure
16%
Unfavorable Risk
16%
Tertiary Care
16%
Renal Disease
16%
Primary Care Physicians
16%
Current Recommendations
16%
Risk-benefit Ratio
16%
Nephrologists
16%
Blood Pressure Goals
16%
Creatinine Clearance
16%
Medication Regimen
16%
Hyperkalemia
16%
Angiotensin Receptor Antagonists
16%
Medication Cost
16%
Acute Renal Failure
16%
Registry Data
16%
Miscommunication
16%
Mutually Exclusive
16%
Medicine and Dentistry
Chronic Kidney Disease
100%
Enzyme Inhibitor
100%
ACE Inhibitor
100%
Pressure Control
100%
Blood Pressure
100%
Angiotensin
100%
Drug Therapy
83%
Antihypertensive Agent
66%
Mean Arterial Pressure
50%
Nephrology
33%
Proteinuria
33%
Health Care Cost
16%
Prospective Study
16%
Diastolic Blood Pressure
16%
Systolic Blood Pressure
16%
Tertiary Care
16%
Nephropathy
16%
Risk-Benefit Ratio
16%
Nephrologist
16%
Acute Kidney Injury
16%
Creatinine Clearance
16%
Hyperkalemia
16%
Angiotensin Receptor Antagonist
16%
Nursing and Health Professions
Blood Pressure
100%
Chronic Kidney Failure
100%
Pressure Control
100%
Angiotensin
100%
Enzyme Inhibitor
100%
Dipeptidyl Carboxypeptidase Inhibitor
100%
Drug Therapy
83%
Antihypertensive Agent
66%
Hospital
50%
Mean Arterial Pressure
50%
Proteinuria
33%
Practice Guideline
16%
Tertiary Health Care
16%
Systolic Blood Pressure
16%
Creatinine Clearance
16%
Hyperkalemia
16%
Acute Kidney Failure
16%
Angiotensin Receptor Antagonist
16%
Nephrologist
16%
Kidney Disease
16%
Diastolic Blood Pressure
16%
Pharmacology, Toxicology and Pharmaceutical Science
Enzyme Inhibitor
100%
Chronic Kidney Failure
100%
Dipeptidyl Carboxypeptidase Inhibitor
100%
Angiotensin
100%
Antihypertensive Agent
66%
Proteinuria
33%
Creatinine
16%
Prospective Study
16%
Kidney Disease
16%
Hyperkalemia
16%
Acute Kidney Failure
16%
Angiotensin Receptor Antagonist
16%
Agricultural and Biological Sciences
Blood Pressure
100%
Canadians
100%
ACE Inhibitor
100%
Angiotensin
100%
Mean Arterial Pressure
50%
Proteinuria
33%
Receptor
16%
Eicosanoid Receptor
16%
Systolic Blood Pressure
16%
Diastolic Blood Pressure
16%
Creatinine
16%
Prospective Study
16%
Neuroscience
Angiotensin
100%
ACE Inhibitor
100%
Enzyme Inhibitor
100%
Nephrology
33%
Creatinine
16%
Angiotensin Receptor
16%
Receptor Antagonist
16%